Home > PJ > The Society

Return to PJ Online Home Page The Pharmaceutical Journal Vol 266 No 7147 p649
May 12, 2001

The Society

Welsh Executive

Welsh pharmacy “not the weakest link”

On April 25, the Welsh Executive annual dinner took place in the 25th year of the executive's existence. Chairman, Colin Ranshaw spoke before proposing the toast of the guests, and Jane Hutt, Social Services of the National Assembly for Wales replied on their behalf

Notwithstanding Ann Robinson's recent gibes about Wales and her inhabitants, pharmacy in Wales is neither weakest link nor should be confined to Room 101. The Welsh Executive, now 25 years old, has always been in the forefront of thinking, as Colin Ranshaw explained: “In a rare example of a health care profession actually getting ahead of the game, the Royal Pharmaceutical Society of Great Britain set out its vision of the future back in 1995, in a strategy called 'Pharmacy in a new age'. I was delighted to reread it and realise just how up to date and relevant it still is.”

There were particular challenges for the profession in Wales which drove the health agenda, he said. Underpinning all NHS initiatives were two statistics: first “the famous 'iceberg' of illness of which the GP just sees the tip which would overwhelm the NHS if were not for the support of professionals such as pharmacists”. This was especially important in the most deprived communities in Wales. Second was the fact that £1 in £8 spent by the NHS went on medicines that had to be used properly.

Devolution had given the health service in Wales the opportunity really to meet the needs of Wales, Mr Ranshaw added. The implementation of the primary care strategy, which was expected to be published in the next few months, would be hard but it would also be a way to liberate the potential of community pharmacy. “That is when the long hard slog will really begin and when cultures have to change,” Mr Ranshaw said.

He also emphasised that, then, pharmacists would be able to realise their professional aspirations “and deliver for Wales a proper return on its investment in pharmacy and prescribed medication”.

The report of the Task and Finish Group on Prescribing was also welcomed by Mr Renshaw, particularly the specific recommendations on repeat dispensing by pharmacists, and the supplementary prescribing rights for pharmacists and nurses and other initiatives in other parts of the health service. “All this adds up to a coherent whole in which each profession is free to do what it does best, and the puzzling hurdles which prevent patients getting their medicines easily and safely are swept away,” he declared.

But, Mr Ranshaw cautioned, to achieve all this community pharmacy needed to work much more closely with GPs and nurses, and also with social services (many of whose clients had pharmaceutical care needs that were not being appropriately met at present).

There were also commercial imperatives to be considered. The NHS, argued Mr Ranshaw “gets its community pharmacy on the cheap” because so much of the costs were borne by the contractor. “Moving towards a system which rewards professionalism therefore remains a major objective.”

On the policy level, “Improving health in Wales” outlined a vision of the NHS with its partners in which pharmacists clearly had much to contribute. This had been nicely complemented by the prescribing Task and Finish Group's report, Mr Ranshaw pointed out and “'Access and excellence' also plays to our strengths”. The primary care strategy would be the final element and would both remove barriers and provide incentives for change.

The pharmacy profession throughout Wales longed to contribute to the new health service that was now emerging. “Since 1995 we have sought a position in which we can contribute that for which we have trained and which the public want from us. It is now much nearer. There are a lot of committed pharmacists out there who have contributed an awful lot. I would like to pay tribute to those who have worked so hard.”

Mr Ranshaw added: “We welcome the way the service in Wales is developing and strongly believe that working with all different professionals in the health service, we can help the NHS, with its partners, take that leap forward which it so clearly needs.”

Pivotal role in health care delivery

In reply, Jane Hutt thanked Mr Renshaw for his comprehensive overview of the issues as they affected the profession in Wales and his aspirations for the future of the profession. “Inspired by what you say I would also like to support his comment on the pharmacist's pivotal role in the delivery of health care in Wales.”

Ms Hutt went on: “I would like to acknowledge the enormous contribution that the Welsh Executive has made, not only to the pharmaceutical profession in Wales, but also for their contribution in supporting the work of the National Assembly.” She highlighted the role played by the Executive in the development of the Assembly's sexual health strategy, support for the emergency contraception campaign and involvement in the mental health strategy. She hoped that they would move forward together to the benefit of patient care.

Ms Hutt outlined some of the achievements of the Welsh Executive in increasing the profile of the profession in Wales by intensive networking with health professional and political representatives. The Welsh Executive was also applauded for its informal meetings involving all sectors of the profession across Wales so that the reply to major initiatives came in a unified voice. She also pointed out how well the profession performed when it was subjected to an Audit Committee report, and that she had heard positive feedback about the performance of those who had appeared before the committee.

Ms Hutt commented on the introduction of prescription exempt charges for people under the age of 25 in Wales. She said: “The important message here is that, when we see something needs doing in Wales and it falls within the scope of the powers of the Assembly, then we will do it. While we will always have regard for developments across the border, we set our own agenda.”

She also spoke about the Task and Finish Group on Prescribing and commented on how the report recognised the valuable but under-utilised skills of pharmacists. “I am keen to redress this, so that we can ensure that patients gain maximum benefit from their medication. We will use [local pharmaceutical services] pilots to explore innovative ways of delivering pharmaceutical care and remove existing service and professional boundaries and encourage joints working across the sectors.”

Ms Hutt also spoke about the contribution the Welsh Centre for Postgraduate Pharmaceutical Education had made to the development of a continuing professional development toolkit for pharmacists. And she also welcomed the Society's initiatives to establish a workforce advisory group.

Back to Top



©The Pharmaceutical Journal